The trademark application Omrifio was filed by Novo Nordisk A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on October 14, 2025, and still open for oppositions.
The application was filed in Danish (English was selected as the second language).
Change of name and address of the trademark registration was recorded on November 19, 2025.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the treatment of diabetes
Pharmaceutical preparations for weight reduction and long term weight loss maintenance
Pharmaceutical preparations for the treatment of liver diseases
Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension
Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.